FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028940135> ?p ?o ?g. }

• W2028940135 endingPage "715" @default.
• W2028940135 startingPage "708" @default.
• W2028940135 abstract "Collectively, the data in both humans and murine models of human primary biliary cirrhosis (PBC) suggest that activated T cells, particularly CD8 T cells, play a critical role in biliary cell destruction. Under physiological conditions, T-cell activation involves two critical signals that involve the major histocompatibility complex and a set of costimulatory molecules, which include a receptor on T cells termed cytotoxic T lymphocyte antigen 4 (CTLA-4). Germane to the studies reported herein, signaling by CTLA-4 has the potential to modulate costimulation and induce inhibitory signals. In this study, we have taken advantage of our well-defined murine model of PBC, in which mice are immunized with 2-octynoic acid coupled to bovine serum albumin (2OA-BSA), leading to the production of high-titer antimitochondrial autoantibodies (AMAs) and portal cellular infiltrates. To investigate the potential of CTLA-4-Ig (immunoglobulin) as an immunotherapeutic agent, we treated mice both before and after induction of autoimmune cholangitis. First, we demonstrate that CTLA-4-Ig treatment, begun 1 day before 2OA-BSA immunization, completely inhibits the manifestations of cholangitis, including AMA production, intrahepatic T-cell infiltrates, and bile duct damage. However, and more critically, treatment with CTLA-4-Ig, initiated after the development of autoimmune cholangitis in previously immunized mice, also resulted in significant therapeutic benefit, including reduced intrahepatic T-cell infiltrates and biliary cell damage, although AMA levels were not altered. Conclusion: These data suggest that an optimized regimen with CTLA-4-Ig has the potential to serve as an investigative therapeutic tool in patients with PBC. (HEPATOLOGY 2013)" @default.
• W2028940135 created "2016-06-24" @default.
• W2028940135 creator A5002731323 @default.
• W2028940135 creator A5013188999 @default.
• W2028940135 creator A5016645912 @default.
• W2028940135 creator A5019715351 @default.
• W2028940135 creator A5029678899 @default.
• W2028940135 creator A5035953102 @default.
• W2028940135 creator A5041092935 @default.
• W2028940135 creator A5041151171 @default.
• W2028940135 creator A5043598034 @default.
• W2028940135 creator A5053475749 @default.
• W2028940135 creator A5055293697 @default.
• W2028940135 creator A5066462726 @default.
• W2028940135 date "2013-02-01" @default.
• W2028940135 modified "2023-10-18" @default.
• W2028940135 title "Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis" @default.
• W2028940135 cites W1558709694 @default.
• W2028940135 cites W1584051973 @default.
• W2028940135 cites W1597917303 @default.
• W2028940135 cites W1650215555 @default.
• W2028940135 cites W1895800559 @default.
• W2028940135 cites W1907829837 @default.
• W2028940135 cites W1968897594 @default.
• W2028940135 cites W1971026698 @default.
• W2028940135 cites W1973040111 @default.
• W2028940135 cites W1973519414 @default.
• W2028940135 cites W1975890506 @default.
• W2028940135 cites W1983427343 @default.
• W2028940135 cites W1984162039 @default.
• W2028940135 cites W1994649501 @default.
• W2028940135 cites W1994969460 @default.
• W2028940135 cites W2019427269 @default.
• W2028940135 cites W2026092903 @default.
• W2028940135 cites W2033410839 @default.
• W2028940135 cites W2035383711 @default.
• W2028940135 cites W2041974941 @default.
• W2028940135 cites W2043007190 @default.
• W2028940135 cites W2046146126 @default.
• W2028940135 cites W2046739604 @default.
• W2028940135 cites W2047283939 @default.
• W2028940135 cites W2048073154 @default.
• W2028940135 cites W2055420557 @default.
• W2028940135 cites W2057968168 @default.
• W2028940135 cites W2063861785 @default.
• W2028940135 cites W2065199309 @default.
• W2028940135 cites W2076067786 @default.
• W2028940135 cites W2079676235 @default.
• W2028940135 cites W2084419632 @default.
• W2028940135 cites W2087757222 @default.
• W2028940135 cites W2091783976 @default.
• W2028940135 cites W2092104164 @default.
• W2028940135 cites W2094526738 @default.
• W2028940135 cites W2100117872 @default.
• W2028940135 cites W2100832209 @default.
• W2028940135 cites W2103877699 @default.
• W2028940135 cites W2106382467 @default.
• W2028940135 cites W2106938111 @default.
• W2028940135 cites W2128119287 @default.
• W2028940135 cites W2138049450 @default.
• W2028940135 cites W2148082560 @default.
• W2028940135 cites W2156213011 @default.
• W2028940135 cites W2162856391 @default.
• W2028940135 cites W2163005321 @default.
• W2028940135 cites W2166804608 @default.
• W2028940135 cites W2168029208 @default.
• W2028940135 cites W2170452393 @default.
• W2028940135 cites W2259025595 @default.
• W2028940135 cites W4229877359 @default.
• W2028940135 cites W4233066604 @default.
• W2028940135 doi "https://doi.org/10.1002/hep.26067" @default.
• W2028940135 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3548049" @default.
• W2028940135 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22996325" @default.
• W2028940135 hasPublicationYear "2013" @default.
• W2028940135 type Work @default.
• W2028940135 sameAs 2028940135 @default.
• W2028940135 citedByCount "87" @default.
• W2028940135 countsByYear W20289401352013 @default.
• W2028940135 countsByYear W20289401352014 @default.
• W2028940135 countsByYear W20289401352015 @default.
• W2028940135 countsByYear W20289401352016 @default.
• W2028940135 countsByYear W20289401352017 @default.
• W2028940135 countsByYear W20289401352018 @default.
• W2028940135 countsByYear W20289401352019 @default.
• W2028940135 countsByYear W20289401352020 @default.
• W2028940135 countsByYear W20289401352021 @default.
• W2028940135 countsByYear W20289401352022 @default.
• W2028940135 countsByYear W20289401352023 @default.
• W2028940135 crossrefType "journal-article" @default.
• W2028940135 hasAuthorship W2028940135A5002731323 @default.
• W2028940135 hasAuthorship W2028940135A5013188999 @default.
• W2028940135 hasAuthorship W2028940135A5016645912 @default.
• W2028940135 hasAuthorship W2028940135A5019715351 @default.
• W2028940135 hasAuthorship W2028940135A5029678899 @default.
• W2028940135 hasAuthorship W2028940135A5035953102 @default.
• W2028940135 hasAuthorship W2028940135A5041092935 @default.
• W2028940135 hasAuthorship W2028940135A5041151171 @default.
• W2028940135 hasAuthorship W2028940135A5043598034 @default.

• next